Interventional Oncology Market by Procedure (Ablation, Particle Embolization, Radiation Therapy), Cancer Type (Bone Metastasis, Breast Cancer, Kidney Cancer), End-Users - Global Forecast 2024-2030

Interventional Oncology Market by Procedure (Ablation, Particle Embolization, Radiation Therapy), Cancer Type (Bone Metastasis, Breast Cancer, Kidney Cancer), End-Users - Global Forecast 2024-2030


The Interventional Oncology Market size was estimated at USD 5.04 billion in 2023 and expected to reach USD 5.43 billion in 2024, at a CAGR 7.86% to reach USD 8.56 billion by 2030.

Global Interventional Oncology Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Interventional Oncology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Interventional Oncology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Interventional Oncology Market, highlighting leading vendors and their innovative profiles. These include Angiodynamics, Atricure, BALT Group, Boston Scientific Ltd., Cook Medical, Eckert & Ziegler BEBIG AG, Integer Holding Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merit Medical, Profound Medical, Siemens Healthineers AG, Sonablate Corp, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Interventional Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Procedure
Ablation

Particle Embolization

Radiation Therapy

Cancer Type
Bone Metastasis

Breast Cancer

Kidney Cancer

Liver Cancer

Lung Cancer

Prostate Cancer

End-Users
Ambulatory Surgery Centers

Hospitals

Research & Academic Institutes

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Interventional Oncology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Interventional Oncology Market?
3. What are the technology trends and regulatory frameworks in the Interventional Oncology Market?
4. What is the market share of the leading vendors in the Interventional Oncology Market?
5. Which modes and strategic moves are suitable for entering the Interventional Oncology Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Interventional Oncology Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in incidence of cancer across the globe and surge in geriatric population
5.1.1.2. Increase in government expenditures for interventional oncology
5.1.1.3. Preference for minimally invasive procedures
5.1.2. Restraints
5.1.2.1. Shortage of trained interventional oncologists
5.1.3. Opportunities
5.1.3.1. Benefits of providing interventional oncology in an outpatient setting
5.1.3.2. New technological advancements for interventional oncology
5.1.4. Challenges
5.1.4.1. Presence of alternative therapies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Interventional Oncology Market, by Procedure
6.1. Introduction
6.2. Ablation
6.3. Particle Embolization
6.4. Radiation Therapy
7. Interventional Oncology Market, by Cancer Type
7.1. Introduction
7.2. Bone Metastasis
7.3. Breast Cancer
7.4. Kidney Cancer
7.5. Liver Cancer
7.6. Lung Cancer
7.7. Prostate Cancer
8. Interventional Oncology Market, by End-Users
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals
8.4. Research & Academic Institutes
9. Americas Interventional Oncology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Interventional Oncology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.
10. South Korea
10.
11. Taiwan
10.
12. Thailand
10.
13. Vietnam
11. Europe, Middle East & Africa Interventional Oncology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.
10. Nigeria
11.
11. Norway
11.
12. Poland
11.
13. Qatar
11.
14. Russia
11.
15. Saudi Arabia
11.
16. South Africa
11.
17. Spain
11.
18. Sweden
11.
19. Switzerland
11.
20. Turkey
11.
21. United Arab Emirates
11.
22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Angiodynamics
13.1.2. Atricure
13.1.3. BALT Group
13.1.4. Boston Scientific Ltd.
13.1.5. Cook Medical
13.1.6. Eckert & Ziegler BEBIG AG
13.1.7. Integer Holding Corporation
13.1.8. Johnson & Johnson Services, Inc.
13.1.9. Medtronic PLC
13.1.
10. Merit Medical
13.1.
11. Profound Medical
13.1.
12. Siemens Healthineers AG
13.1.
13. Sonablate Corp
13.1.
14. Stryker Corporation
13.1.
15. Terumo Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
FIGURE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
FIGURE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings